J. Safra Sarasin Holding AG trimmed its position in Avantor, Inc. (NYSE:AVTR – Free Report) by 67.3% in the 3rd quarter, Holdings Channel.com reports. The fund owned 38,936 shares of the company’s stock after selling 80,058 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in Avantor were worth $486,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also bought and sold shares of the company. EverSource Wealth Advisors LLC boosted its position in shares of Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares in the last quarter. Strategic Wealth Investment Group LLC purchased a new stake in shares of Avantor during the second quarter worth about $32,000. FNY Investment Advisers LLC purchased a new position in shares of Avantor in the 2nd quarter valued at approximately $36,000. Osaic Holdings Inc. raised its position in shares of Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares during the last quarter. Finally, Farther Finance Advisors LLC boosted its stake in Avantor by 172.1% in the 3rd quarter. Farther Finance Advisors LLC now owns 3,709 shares of the company’s stock worth $46,000 after purchasing an additional 2,346 shares in the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other Avantor news, Director Sanjeev K. Mehra acquired 350,000 shares of the stock in a transaction that occurred on Friday, December 5th. The stock was bought at an average cost of $11.09 per share, for a total transaction of $3,881,500.00. Following the completion of the transaction, the director owned 350,000 shares of the company’s stock, valued at approximately $3,881,500. The trade was a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.20% of the company’s stock.
Avantor Price Performance
Avantor (NYSE:AVTR – Get Free Report) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $0.22 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). The company had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.65 billion. Avantor had a positive return on equity of 10.91% and a negative net margin of 1.25%.The business’s quarterly revenue was down 5.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.26 EPS. On average, equities analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several equities analysts recently issued reports on the company. UBS Group set a $12.00 target price on Avantor in a research report on Thursday, October 30th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $12.00 price objective (down from $14.00) on shares of Avantor in a report on Thursday, October 30th. Zacks Research raised Avantor from a “strong sell” rating to a “hold” rating in a report on Monday, December 29th. TD Cowen decreased their price objective on shares of Avantor from $14.00 to $12.00 and set a “hold” rating for the company in a research note on Wednesday, January 7th. Finally, Bank of America lowered shares of Avantor from a “buy” rating to a “neutral” rating and set a $13.00 price objective on the stock. in a research note on Monday, December 15th. Three equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Avantor presently has an average rating of “Hold” and a consensus target price of $13.60.
View Our Latest Stock Analysis on AVTR
Avantor Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
See Also
- Five stocks we like better than Avantor
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
- Buy this Gold Stock Before May 2026
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- New Banking Law #1582 Could Unlock $21 Trillion for Americans
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
